[
  {
    "ts": null,
    "headline": "Trading Rotation Kicks Off 2nd Half of 2025",
    "summary": "Tech stocks lagged after a very strong first half of the year, while healthcare led the way.",
    "url": "https://finnhub.io/api/news?id=9f001392d0002986a87586a58bfaf4a7ff645f5ecc55740cb69c6ac029fee036",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751407740,
      "headline": "Trading Rotation Kicks Off 2nd Half of 2025",
      "id": 135699842,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Tech stocks lagged after a very strong first half of the year, while healthcare led the way.",
      "url": "https://finnhub.io/api/news?id=9f001392d0002986a87586a58bfaf4a7ff645f5ecc55740cb69c6ac029fee036"
    }
  },
  {
    "ts": null,
    "headline": "Stock Market Today: Dow jumps; S&P 500 and Nasdaq slip",
    "summary": "President Trump and Elon Musk continue to feud. Nike and Apple boost the Dow.",
    "url": "https://finnhub.io/api/news?id=6ac22dc656ad94e90e74c223a57e6e0a640156b80dbc5e8dfb30ec9e22b4f313",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751386283,
      "headline": "Stock Market Today: Dow jumps; S&P 500 and Nasdaq slip",
      "id": 135694490,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "President Trump and Elon Musk continue to feud. Nike and Apple boost the Dow.",
      "url": "https://finnhub.io/api/news?id=6ac22dc656ad94e90e74c223a57e6e0a640156b80dbc5e8dfb30ec9e22b4f313"
    }
  },
  {
    "ts": null,
    "headline": "Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know",
    "summary": "Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
    "url": "https://finnhub.io/api/news?id=42d8ecd4da11cd1c313dbbc8a12cec42bc6d7092ae956d6ac76736a151eb6f0f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751374803,
      "headline": "Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know",
      "id": 135694217,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
      "url": "https://finnhub.io/api/news?id=42d8ecd4da11cd1c313dbbc8a12cec42bc6d7092ae956d6ac76736a151eb6f0f"
    }
  },
  {
    "ts": null,
    "headline": "Dow up nearly 500 points on gains in Amgen, Merck stocks",
    "summary": "Dow up nearly 500 points on gains in Amgen, Merck stocks",
    "url": "https://finnhub.io/api/news?id=1c6d3b4186a76d5225de09218dc8bc43210d3a4778efb05914b4baa6e8a50e47",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751372100,
      "headline": "Dow up nearly 500 points on gains in Amgen, Merck stocks",
      "id": 135729841,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Dow up nearly 500 points on gains in Amgen, Merck stocks",
      "url": "https://finnhub.io/api/news?id=1c6d3b4186a76d5225de09218dc8bc43210d3a4778efb05914b4baa6e8a50e47"
    }
  },
  {
    "ts": null,
    "headline": "Dow's 300-point rally highlighted by gains in Amgen, Merck shares",
    "summary": "Dow's 300-point rally highlighted by gains in Amgen, Merck shares",
    "url": "https://finnhub.io/api/news?id=d71523d544b94030d53eb6b87630c8a93b7a7ac763b72501532ba7fd0a8134ed",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751368440,
      "headline": "Dow's 300-point rally highlighted by gains in Amgen, Merck shares",
      "id": 135729800,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Dow's 300-point rally highlighted by gains in Amgen, Merck shares",
      "url": "https://finnhub.io/api/news?id=d71523d544b94030d53eb6b87630c8a93b7a7ac763b72501532ba7fd0a8134ed"
    }
  },
  {
    "ts": null,
    "headline": "Amgen and Zai Lab’s trial of gastric cancer therapy meets primary endpoint",
    "summary": "The placebo-controlled trial involved 547 subjects across 300 sites in 37 nations.",
    "url": "https://finnhub.io/api/news?id=aeb955f6124e0724516fa88ed315742aa06f928edd190de64906d0ba7dae2e93",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751362349,
      "headline": "Amgen and Zai Lab’s trial of gastric cancer therapy meets primary endpoint",
      "id": 135691733,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "The placebo-controlled trial involved 547 subjects across 300 sites in 37 nations.",
      "url": "https://finnhub.io/api/news?id=aeb955f6124e0724516fa88ed315742aa06f928edd190de64906d0ba7dae2e93"
    }
  }
]